Distigmine Bromide
Catalog No. A22624
Distigmine Bromide, also known as Ubretid and BC-51, is an acetylcholinesterase inhibitor used for the treatment of underactive neurogenic bladder and myasthenia gravis.
| Catalog Num | A22624 |
|---|---|
| M. Wt | 560.33 |
| Formula | C22H32Br2N4O3 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 15876-67-2 |
| Synonyms | |
| SMILES | O=C(OC1=C[N+](C)=CC=C1)N(CCCCCCN(C(C2=C[N+](C)=CC=C2)=O)C)C.[Br-].[Br-] |
Distigmine Bromide, also known as Ubretid and BC-51, is an acetylcholinesterase inhibitor used for the treatment of underactive neurogenic bladder and myasthenia gravis.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 17.85 mL | 89.23 mL | 178.47 mL |
| 0.5 mM | 3.57 mL | 17.85 mL | 35.69 mL |
| 1 mM | 1.78 mL | 8.92 mL | 17.85 mL |
| 5 mM | 0.36 mL | 1.78 mL | 3.57 mL |
*The above data is based on the productmolecular weight 560.33. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.